We might be a step closer to curing HIV, as researchers have developed a way to knock out a version of the virus lurking in the body. Using something called an HIV-like particle (HLP)—which are dead ...
In the study published in the journal Emerging Microbes and Infections, the team demonstrated that the patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective ...
Study dissects HIV reservoir clones that persist on ART, revealing how CD8+ T cells and resistance pathways could be ...
“Latent herpes viruses have the potential to reactivate in people living with HIV which can lead to neuroinflammation and impact long-term brain health,” said Shirin Mazumder, MD, infectious diseases ...
A research team led by Professor Chu Hin (first right) and Professor Chen Zhiwei (first left) has discovered that inhibiting the BRD9 protein can effectively reactivate latent HIV-1. When used in ...
A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now a new study led by Stanford researchers has revealed that EBC-46 also shows ...
LITTLE ROCK, Ark. (KATV) — The National Institutes of Health (NIH) has granted the University of Arkansas for Medical Sciences (UAMS) a five-year $2.9 million research grant for their discovery of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results